New York, NY, United States of America

Zimra Israel

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Wyeth. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zimra Israel. Retrieved from https://idiyas.com/inventor/zimra-israel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zimra Israel: Innovator in HIV Immunogenic Compositions

Introduction

Zimra Israel is a notable inventor based in New York, NY (US). She has made significant contributions to the field of immunology, particularly in the development of compositions aimed at inducing an immune response to HIV. Her innovative work is crucial in the ongoing fight against this global health challenge.

Latest Patents

Zimra Israel holds a patent for "Immunogenic compositions for inducing an immune response to HIV." This invention involves combinations of two, three, or four plasmids, each expressing a defined antigen. These antigens may be single or fused, enhancing the potential effectiveness of the immune response against HIV.

Career Highlights

Zimra Israel is associated with Wyeth, a prominent company in the pharmaceutical industry. Her work at Wyeth has allowed her to focus on groundbreaking research that addresses critical health issues. With her expertise, she has contributed to advancements in immunogenic therapies.

Collaborations

Zimra has collaborated with esteemed colleagues, including Maninder K Sidhu and John Hayward Eldridge. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to impactful research outcomes.

Conclusion

Zimra Israel's contributions to immunogenic compositions for HIV represent a significant advancement in medical science. Her work not only showcases her innovative spirit but also highlights the importance of collaboration in achieving breakthroughs in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…